Lambert-Eaton Myasthenic Syndrome VGCC Probability

Estimate probability of Lambert-Eaton myasthenic syndrome and malignancy (SCLC) using clinical features, VGCC antibody titer, and DELTA-P paraneoplastic score.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Estimate probability of Lambert-Eaton myasthenic syndrome and malignancy (SCLC) using clinical features, VGCC antibody titer, and DELTA-P paraneoplastic score

Each component has a specific meaning:

  • Clinical features — The clinical features recorded for the scenario being assessed.
  • VGCC antibody titer — The vgcc antibody titer recorded for the scenario being assessed.

Note: Interpret the lems vgcc probability result against the thresholds and context described above.

How to Use

Enter the clinical features, VGCC antibody titer for the scenario you are assessing. Estimate probability of Lambert-Eaton myasthenic syndrome and malignancy (SCLC) using clinical features, VGCC antibody titer, and DELTA-P paraneoplastic score. Use the lems vgcc probability result to inform your calculation.

Frequently Asked Questions